Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5288698
Max Phase: Preclinical
Molecular Formula: C32H52N10O13
Molecular Weight: 784.83
Associated Items:
ID: ALA5288698
Max Phase: Preclinical
Molecular Formula: C32H52N10O13
Molecular Weight: 784.83
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)N[C@H](C(=O)N[C@H](C(=O)NCCCN[C@@H](C[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)C(=O)O)[C@@H](O)C(C)C)[C@@H]1CCNC(=N)N1)C(=O)O
Standard InChI: InChI=1S/C32H52N10O13/c1-13(2)19(29(51)52)40-31(53)41-20(15-6-10-36-30(33)37-15)26(48)39-21(22(44)14(3)4)25(47)35-9-5-8-34-16(28(49)50)12-17-23(45)24(46)27(55-17)42-11-7-18(43)38-32(42)54/h7,11,13-17,19-24,27,34,44-46H,5-6,8-10,12H2,1-4H3,(H,35,47)(H,39,48)(H,49,50)(H,51,52)(H3,33,36,37)(H,38,43,54)(H2,40,41,53)/t15-,16-,17+,19-,20-,21-,22-,23+,24+,27+/m0/s1
Standard InChI Key: XPXUWQUPWCZIKW-SGRJWZIVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 784.83 | Molecular Weight (Monoisotopic): 784.3715 | AlogP: -4.74 | #Rotatable Bonds: 19 |
Polar Surface Area: 358.65 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.42 | CX Basic pKa: 11.02 | CX LogP: -8.63 | CX LogD: -8.63 |
Aromatic Rings: 1 | Heavy Atoms: 55 | QED Weighted: 0.06 | Np Likeness Score: 0.55 |
1. Bugg TD, Rodolis MT, Mihalyi A, Jamshidi S.. (2016) Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides., 24 (24): [PMID:27021004] [10.1016/j.bmc.2016.03.018] |
Source(1):